Non-cytokine activation immunoprofiling to differentiate treatment status in latent tuberculosis infection

Conclusion: The strategy of non-cytokine activation immunoprofiling is capable to differentiate treatment status in LTBI, and may stratify TB reactivation risk.

Source: European Respiratory Journal - October 28, 2020 Category: Respiratory Medicine Authors: Escalante, P., Van Keulen, V., Erskine, C., Peikert, T. Tags: Tuberculosis Source Type: research